EDIT
Price
$3.19
Change
+$0.34 (+11.93%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
488.01M
36 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$7.79
Change
+$0.73 (+10.34%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
435.97M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs SGMT

EDIT vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
EDIT vs. SGMT commentary
Jun 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and SGMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2026
Stock price -- (EDIT: $2.85 vs. SGMT: $7.06)
Brand notoriety: EDIT and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 237% vs. SGMT: 333%
Market capitalization -- EDIT: $488.01M vs. SGMT: $481.28M
EDIT [@Biotechnology] is valued at $488.01M. SGMT’s [@Biotechnology] market capitalization is $481.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $126.81B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 3 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 3 bullish, 7 bearish.
  • SGMT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +1.79% price change this week, while SGMT (@Biotechnology) price change was -0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.89%. For the same industry, the average monthly price growth was -0.41%, and the average quarterly price growth was +1915.34%.

Reported Earning Dates

EDIT is expected to report earnings on Aug 05, 2026.

SGMT is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+1.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($488M) has a higher market cap than SGMT($436M). EDIT YTD gains are higher at: 39.024 vs. SGMT (19.257). SGMT has higher annual earnings (EBITDA): -48.74M vs. EDIT (-100.08M). EDIT has more cash in the bank: 124M vs. SGMT (105M). SGMT has less debt than EDIT: SGMT (39K) vs EDIT (17.3M). EDIT has higher revenues than SGMT: EDIT (38.7M) vs SGMT (0).
EDITSGMTEDIT / SGMT
Capitalization488M436M112%
EBITDA-100.08M-48.74M205%
Gain YTD39.02419.257203%
P/E RatioN/AN/A-
Revenue38.7M0-
Total Cash124M105M118%
Total Debt17.3M39K44,359%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITSGMT
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAXLX10.940.07
+0.64%
Impax Large Cap Fund Individual Investor
FOBAX20.340.08
+0.39%
Tributary Balanced Instl
MIFOX30.31-0.08
-0.26%
Marsico Focus Institutional
VHIAX39.18-0.12
-0.31%
JPMorgan Growth Advantage A
BMSRX17.23-0.07
-0.40%
MFS Blended Research Mid Cap Eq R1

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRBU. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
N/A
CRBU - EDIT
64%
Loosely correlated
N/A
BEAM - EDIT
63%
Loosely correlated
N/A
PRME - EDIT
60%
Loosely correlated
N/A
NTLA - EDIT
57%
Loosely correlated
N/A
CRSP - EDIT
56%
Loosely correlated
N/A
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+2.92%
VIR - SGMT
41%
Loosely correlated
+1.52%
INBX - SGMT
38%
Loosely correlated
-0.52%
GOSS - SGMT
37%
Loosely correlated
-4.96%
EDIT - SGMT
37%
Loosely correlated
+4.01%
VKTX - SGMT
37%
Loosely correlated
+2.84%
More